WCF
HAE icon

West Coast Financial’s Haemonetics HAE Stock Holding History

West Coast Financial’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-47,212
Closed -$3.69M – 164
2024
Q4 		$3.69M Buy
47,212
+30
+0.1% +$2.41K 0.41% 48
2024
Q3 		$3.79M Buy
47,182
+1,013
+2% +$81.8K 0.42% 52
2024
Q2 		$3.82M Buy
+46,169
New +$4.06M 0.45% 49

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

West Coast Financial's HAE Position: Q1 2025 in Review

West Coast Financial sold out of Haemonetics (HAE) in Q1 2025, closing a stake of 47,212 shares — an estimated $3.69M sold.

West Coast Financial first reported a position in HAE in Q2 2024 and held it in 3 quarters. The position peaked at $3.82M in Q2 2024. 314 funds tracked by Wall St. Rank hold HAE as of Q1 2025.

  • West Coast Financial reported no remaining Haemonetics position as of Q1 2025 after selling out during the quarter.
  • West Coast Financial sold 47,212 Haemonetics shares in Q1 2025, an estimated $3.69M.
  • West Coast Financial first reported a position in Haemonetics in Q2 2024 and held it in 3 quarters.
  • West Coast Financial's Haemonetics position peaked at $3.82M in Q2 2024.
  • 314 funds tracked by Wall St. Rank held Haemonetics as of Q1 2025.

Based on West Coast Financial's 13F filing for Q1 2025, filed 11 Apr 2025.